Breaking
Unseen Profit
Author

admin

Browsing
Stocks

Is it a golden opportunity to buy the Nasdaq 100 index crash?

The Nasdaq 100 index has crashed into a correction as concerns about Donald Trump’s reciprocal tariffs and the artificial intelligence (AI) industries remain. It closed at $19,580 on Wednesday and then plunged by over 600 points in the futures market. This article explains why this crash could be a golden opportunity to buy these stocks.

2 reasons why the Nasdaq 100 index has crashed

There are two main reasons why the Nasdaq 100 index has crashed this year. First, there are serious concerns about the artificial intelligence (AI) industry, which is showing signs of slowing down. This explains why most AI stocks like NVIDIA, AMD, Intel, BigBear, C3.ai, and SoundHound have plummeted this year.

These fears have been compounded by the ongoing trade war, which escalated on Wednesday when Trump unveiled his Liberation Day tariffs on all US imports. The US will impose 10% to 35% tariffs on all imported goods. 

Trump aims to use these tariffs to increase the government’s revenue and reduce the deficit, a move that will be difficult to achieve. Analysts believe that these tariffs will lead to weak consumption in the US and even sink the US into a recession this year.

Indeed, flash data by the Atlanta Fed show that the US economy likely contracted in the first quarter, ending a long period of growth. PIMCO, Citi, and Goldman Sachs have boosted their recession odds lately. 

Nasdaq 100 index chart | Source: TradingView

Is the ongoing Nasdaq index crash a good buying opportunity

The financial market is often driven by fear and greed. Indeed, the CNN Money fear and greed index has now crashed to the extreme fear zone of 15. This decline will likely continue as the markets continue sinking. 

There is a likelihood that the Nasdaq 100 index will continue crashing in the coming weeks as investors digest these risks. 

However, some analysts believe that the ongoing plunge is a golden opportunity to buy the dip in tech stocks for a few reasons.

First, while a recession is highly feared, evidence shows that it is usually the best time to buy the dip in many quality stocks that become bargains. Three good examples of this are the dot com bubble, the Global Financial Crisis, and the Covid-19 pandemic. Investors who bought during those dips did better than those who bought at the top.

For example, the Nasdaq 100 index crashed from $9,715 in late February 2020 to $6,765 in early March as the COVID-19 pandemic started. Investors who sold in panic and sold during the crash, missed an opportunity that pushed the index to over $22,000 this year.

Federal Reserve interventions

The other reason why this may be a golden opportunity to invest in the Nasdaq 100 index is that the Fed will always intervene when things are not going on well.

In this case, the bank may decide to cut interest rates and even relaunch its quantitative easing policies. It will do that to flood the market with liquidity and grow the economy.

The Nasdaq 100 index often does well when the Fed is intervening. This happened in all the last recessions.

US government stimulus

There are rising odds that the US government will also intervene if there is a crisis, a move that will support stocks. Reports are that the Trump administration is considering raising money for the agricultural sector that tariffs will decimate. These funds could be in the billions of dollars. 

The administration may also decide to bail out many small companies that will be forced to close shop because of these tariffs. US stocks tend to do well when the government is printing money and offering it to businesses and individuals.

The post Is it a golden opportunity to buy the Nasdaq 100 index crash? appeared first on Invezz

Keep Reading
Stocks

European, Asian pharma stocks rally as Trump spares sector from reciprocal tariffs but the cheer may be shortlived

Pharmaceutical stocks saw strong gains on Thursday after US President Donald Trump announced that pharmaceuticals would be exempt from the latest round of reciprocal tariffs on global imports.

The exemption has provided a much-needed boost to the sector, particularly for Indian and European drugmakers, which rely heavily on US sales.

However, analysts have cautioned that broader tariff risks still loom over the industry.

European pharma stocks climb, but uncertainty remains

Following Trump’s announcement, major pharmaceutical stocks across Europe and Asia posted gains.

In the UK, AstraZeneca and GlaxoSmithKline (GSK) both climbed about 1.5%, while Swiss drugmaker Novartis gained 0.69%.

France’s Sanofi also edged higher by 0.3%.

However, Swiss pharmaceutical giant Roche fell 2.3% after its multiple sclerosis drug Ocrevus failed to meet its primary endpoint in a key clinical trial.

While the immediate exemption of pharmaceuticals has been welcomed by the industry, analysts warn that uncertainties remain.

Shore Capital healthcare analyst Sean Conroy noted that a White House fact sheet indicated pharmaceuticals were excluded from the new tariff measures.

However, he added, “It is still somewhat unclear whether the broader-reaching 10% baseline tariffs could still be levied against imported drugs and vaccines.”

Similarly, analysts at Bryan Garnier Research pointed out that Trump’s mixed messaging left room for potential future tariff risks.

The US president had remarked that drugmakers “will come roaring back to the US, because if they don’t, they got a big tax to pay.”

Asian, Indian healthcare stocks rally

Asian healthcare stocks also rallied, led by Indian generic drugmakers, even as the broader market declined.

The CNX Pharma index, which tracks Indian pharmaceutical companies, surged more than 3%, marking its biggest one-day gain in 10 months.

In contrast, India’s benchmark Nifty 50 index fell 0.25% on the day.

Sun Pharma, Cipla, and Dr. Reddy’s Laboratories, the country’s three largest drugmakers by revenue, gained between 3% and 6%.

India, one of the largest suppliers of generic medicines to the US, stands to benefit the most from the exemption.

The US accounted for nearly a third, or $9 billion, of India’s total pharmaceutical exports last fiscal year, with most of these being low-cost generic drugs.

Japan’s pharmaceutical sector also benefited, with Takeda Pharmaceuticals and Daiichi Sankyo advancing 2% and 2.7%, respectively.

However, Japan’s broader Nikkei 225 index tumbled to an eight-month low, reflecting investor concerns over the wider impact of US tariffs on global trade.

Japan’s exports to the US were also substantial, amounting to $6.34 billion in 2023, according to data from research firm OEC.

Jefferies analysts noted that while Indian drugmakers “can breathe easy for now,” the risk of future tariffs remains.

“Higher tariffs at a later date cannot be ruled out, but for now, this exemption allows Indian firms to maintain their competitive edge in the US market,” Jefferies said in a note.

What to expect in the coming days?

Looking ahead, analysts suggest that pharmaceutical companies will closely monitor the Trump administration’s stance on trade policies.

Bloomberg has reported that the US government is considering launching a Section 232 investigation into pharmaceuticals, semiconductors, and critical minerals, similar to previous probes that resulted in tariffs on cars and aluminium.

BNP Paribas India analyst Tausif Shaikh stated, “Assuming a 10% tariff is imposed on pharma products, we expect the impact to be negligible. However, with the sector exempted from reciprocal tariffs currently, we expect a relief rally for the Nifty Pharma Index, after its 11% year-to-date decline.”

While the immediate outlook for pharmaceutical stocks appears positive, the industry remains vulnerable to policy shifts in the ongoing US trade war.

Investors and drugmakers alike will be watching closely for any further developments from Washington.

The post European, Asian pharma stocks rally as Trump spares sector from reciprocal tariffs but the cheer may be shortlived appeared first on Invezz

Keep Reading
Politics

China’s Dongfeng and Changan in advanced merger talks: what it means for Ford, Nissan, and the global auto industry

Two of China’s largest state-owned automakers, Dongfeng Motor and Changan Automobile, are in advanced discussions to merge, a deal that could create a powerful new player in the global auto industry while raising concerns for their American and Japanese partners.

The New York Times reported Tuesday that the two companies have held detailed negotiations and informed their foreign partners of their plans, according to sources familiar with the matter.

The merger would represent a major consolidation of China’s automotive sector, the world’s largest, as Beijing pushes for greater efficiency and an accelerated transition to electric vehicles (EVs).

Both Dongfeng and Changan currently have excess production capacity for gasoline-powered vehicles, and the Chinese government sees their union as a way to phase out older plants while bolstering EV production.

Together, Dongfeng and Changan manufacture about five million cars annually—more than Ford Motor and nearly as many as General Motors or Stellantis, the parent company of Fiat, Chrysler, and Peugeot.

Despite their scale, both companies have struggled with underutilized production lines.

A merger would allow the companies to consolidate operations, reduce costs, and compete more effectively with China’s growing roster of private EV makers such as BYD and Nio.

If Dongfeng and Changan are successfully reorganized, the new auto group will have annual sales of about 4.58 million units and will overtake BYD to become China’s No. 1 carmaker, as well as the world’s fifth-largest auto group, 36kr said in an earlier report.

Foreign partnerships with Ford, Nissan, and Honda under scrutiny

The proposed merger has raised concerns among the companies’ foreign partners.

Changan has been Ford’s primary partner in China for over two decades, while Dongfeng has long-standing joint ventures with Nissan and Honda.

If the newly merged entity shifts focus toward independent EV production, these partnerships could be disrupted, affecting foreign automakers’ presence in the Chinese market.

The deal could also attract attention from the United States.

Changan is owned by China South Industries Group, a military contractor, while Dongfeng is a key supplier of military vehicles to the People’s Liberation Army (PLA).

The merger could result in a larger state-backed military supplier, heightening scrutiny from the Trump administration and potentially complicating trade relations between China and the US.

China’s overcapacity in auto production is not sustainable

China has been grappling with a surplus of auto production capacity, fuelled by state-backed loans that have allowed automakers to expand aggressively.

While demand for EVs has surged—accounting for over half of all car sales in China since mid-2024—traditional gasoline vehicle sales have struggled.

“The Chinese auto sector is at the start of a sweeping consolidation. We believe capacity cuts are necessary to restore profits, with many entities on an unsustainable path,” S&P Global said in an analysis.

Dongfeng’s factories operated at just 48% capacity last year, while Changan’s were at 47%, well below the profitability threshold of 60-80%.

With excess supply, China has been ramping up auto exports, triggering pushback from Western governments.

Both the US and the European Union have imposed tariffs on Chinese-made cars, aiming to protect their domestic auto industries from an influx of low-cost electric vehicles.

A growing military role

Beyond commercial vehicles, the merger could solidify Dongfeng and Changan’s role as major defense contractors.

Dongfeng has a history of producing military vehicles, including trucks, troop carriers, and launch platforms for missiles and drones.

In 2015, the company supplied 180 vehicles for a high-profile military parade in Beijing, and it is expected to play a similar role in the upcoming 80th-anniversary parade marking Japan’s defeat in World War II.

China has prioritized self-reliance in defense manufacturing, ensuring that military vehicles and components are produced entirely within the country.

Dongfeng has been at the forefront of this initiative, manufacturing everything from engines to the smallest screws domestically.

The post China’s Dongfeng and Changan in advanced merger talks: what it means for Ford, Nissan, and the global auto industry appeared first on Invezz

Keep Reading
Politics

S&P, Nasdaq rise as investors await US tariff clarity; Johnson & Johnson slips, PVV Corp jumps

The S&P 500 experienced volatility on Tuesday and was in the green.

Investors were awaiting clarity from US President Donald Trump regarding tariff policy, and weaker-than-expected economic data also put pressure on Wall Street.

The broad market index was up 0.5% from the previous close.

The Dow Jones Industrial Average climbed 0.2%, while the Nasdaq Composite surged 1% on Tuesday. 

The Institute for Supply Management’s manufacturing survey indicated a contraction in the US economy, and the Bureau of Labor Statistics reported that job openings were below expectations. 

Due to the threat of tariffs and lower-than-expected economic data, investor confidence fell on Tuesday.

“Usually, after a disappointing first quarter, investors look forward to better opportunities ahead,” David Morrison, senior market analyst at Trade Nation, said. 

But that doesn’t appear to be the case now. Instead, there’s one word which comes up repeatedly when attempting to describe the current trading environment, and that is: uncertain.

“And the reason for that uncertainty is, of course, Trump’s tariffs. President Trump has promised ‘retaliatory’ tariffs on all US trading partners, along with a 25% levy on US car imports, starting tomorrow, or ‘Liberation Day’ if you’re a member of the Trump Administration,” Morrison added. 

The Trump administration is contemplating imposing tariffs of approximately 20% on the majority of imports into the US, as reported by The Washington Post on Tuesday. 

The report, citing three sources familiar with the matter, emphasised that no definitive decision has been reached.

Morrison noted:

The trouble is that there have been so many contradictory statements about what this may mean, that markets can’t handicap the outcomes. It seems increasingly plausible that Trump and his administration are also undecided.

US job openings decline

The labor market continued to normalize in February from the pandemic’s massive supply-demand shock, and job openings declined slightly.

Available positions decreased by 194,000 from January to 7.57 million, according to a Tuesday report from the Bureau of Labor Statistics. This figure is slightly lower than the Dow Jones estimate of 7.6 million.

The ratio of openings to available workers decreased to 1.07 to 1, and the openings rate as a share of the labor force decreased 0.2 percentage points to 4.5%.

The Job Openings and Labor Turnover Survey indicated that other measures of quits, hires, layoffs, and separations showed minimal change.

Johnson & Johnson slips

Johnson & Johnson’s shares experienced a more than 5% decline following a US bankruptcy judge’s rejection of the company’s proposed $10 billion settlement.

This settlement was intended to resolve thousands of lawsuits claiming that Johnson & Johnson’s talc-based products, including its iconic baby powder, caused ovarian cancer in users. 

The judge’s decision means that Johnson & Johnson will now have to face these lawsuits in court, potentially leading to a lengthy and costly legal battle. 

This development has understandably rattled investors, leading to the drop in the company’s share price. 

The outcome of these lawsuits will have significant implications not only for Johnson & Johnson’s financial health but also for its reputation and the future of its talc-based products.

PVH Corp soars on strong Q4 earnings

PVH Corp, the parent company of renowned fashion brands Calvin Klein and Tommy Hilfiger, experienced a significant surge in its stock price, jumping 17.4%, following the release of its fourth-quarter earnings report. 

The company exceeded market expectations, reporting earnings per share (EPS) of $3.27, excluding items, on revenue of $2.37 billion. 

This performance surpassed the consensus estimates of analysts polled by LSEG, who had projected EPS of $3.21 and revenue of $2.33 billion.

The stronger-than-anticipated results can be attributed to several factors, including robust sales of both Calvin Klein and Tommy Hilfiger products, particularly in international markets. 

The post S&P, Nasdaq rise as investors await US tariff clarity; Johnson & Johnson slips, PVV Corp jumps appeared first on Invezz

Keep Reading
Politics

UnitedHealthcare CEO Brian Thompson murder case: DOJ to seek death penalty for Luigi Mangione

The US Department of Justice has announced its intent to seek the death penalty for Luigi Mangione, the 26-year-old charged with the December murder of UnitedHealthcare CEO Brian Thompson.

Attorney General Pam Bondi confirmed the decision on Tuesday, stating that the high-profile assassination demands the “ultimate punishment.”

The case has ignited fierce debate over federal capital punishment, political motives, and the broader implications of violent crime policies under President Donald Trump’s administration.

Federal prosecutors pursue maximum sentence

Mangione is facing multiple federal charges, including murder, stalking, and weapons violations, in the US District Court in Manhattan.

The DOJ has characterized the killing as a premeditated act of political violence, citing extensive planning and execution in a public setting.

Prosecutors argue that Mangione’s attack outside the Hilton Hotel in Midtown Manhattan on December 4 was designed to provoke discourse on the healthcare industry.

Attorney General Bondi justified the death penalty pursuit, stating,

Brian Thompson was a devoted father and a respected leader. His murder was a calculated act of terror. This administration remains committed to ensuring justice and reinforcing law and order.

Defense calls execution decision ‘political’

Mangione’s legal team, led by defense attorney Karen Agnifilo, has condemned the decision, accusing the DOJ of leveraging the case for political gain.

“By seeking to execute Luigi Mangione, the Justice Department is prioritizing a political agenda over justice,” Agnifilo said.

“This move contradicts recommendations from local prosecutors and ignores historical precedent.”

The defense maintains that Mangione’s prosecution has been shaped by a broader crackdown on violent crime under Trump’s leadership. Agnifilo further accused the government of defending what she described as a “corrupt and exploitative healthcare system.”

Trump’s death penalty agenda and policy shifts

The decision to seek capital punishment follows Trump’s executive order reinstating the federal death penalty on his first day in office.

This directive mandates prosecutors to pursue execution for crimes deemed severe enough to warrant the punishment.

The policy shift marks a stark contrast from the Biden administration’s 2021 moratorium on federal executions.

Federal executions resumed under Trump in 2020, with 13 individuals put to death during his first term—the highest number in modern US history.

The Death Penalty Information Center reports that only three federal executions had been carried out in the previous two decades before Trump reinstated them.

Mangione’s arrest and ongoing legal battles

Mangione was arrested five days after Thompson’s murder at a McDonald’s in Altoona, Pennsylvania.

Authorities found him in possession of a firearm, silencer, ammunition, fake identification documents, and a US passport.

The accused has yet to enter a plea in federal court but has pleaded not guilty to state charges in Manhattan Supreme Court, where he faces life imprisonment without parole if convicted.

New York does not have the death penalty, further complicating jurisdictional proceedings.

In February, US District Judge Katherine Parker appointed a death penalty expert to Mangione’s defense team at the request of the Federal Defenders of New York.

The appointment underscores capital punishment cases’ complexities and the legal battles ahead.

DOJ labels murder a ‘calculated political act’

The DOJ argues that Mangione’s crime was not an isolated act of violence but rather a politically motivated assassination.

A DOJ statement released Tuesday claimed, “Mangione’s actions involved substantial planning and premeditation, putting numerous bystanders at risk.”

Prosecutors allege that Mangione targeted Thompson specifically to highlight grievances against the US healthcare system.

Despite mounting legal challenges, federal prosecutors remain firm in their pursuit of the death penalty.

The case is expected to set a precedent for future capital punishment rulings under the Trump administration’s law-and-order policies

The post UnitedHealthcare CEO Brian Thompson murder case: DOJ to seek death penalty for Luigi Mangione appeared first on Invezz

Keep Reading
Politics

Hedge funds exit Asian markets ahead of US tariff announcement on April 2

Hedge funds pulled back from Asian markets last week, shedding stocks and reducing leveraged positions as they prepared for US President Donald Trump’s announcement of new reciprocal tariffs on April 2.

South Korea, China’s onshore markets, and Taiwan saw the heaviest selling, while hedge funds also ramped up short bets in Japan, Morgan Stanley noted in a prime brokerage report this week.

The shift in positioning reflects growing uncertainty over Trump’s latest trade measures, which could sharply increase tariff rates and disrupt global commerce.

Export-driven Asian economies remain particularly exposed to US tariff risks.

According to a recent US Treasury report, China, Vietnam, Japan, and Taiwan hold the largest trade surpluses with the US, making them vulnerable to any retaliatory action.

The anticipated tariffs could further escalate tensions between Washington and its key trading partners, with analysts warning of potential spillover effects on global supply chains.

Asian stock markets’ reaction to tariff concerns

Asian stock markets have already felt the pressure of tariff concerns.

Since March 26, when Trump announced a 25% tariff on imported cars, Japan’s Nikkei 225 index has declined by 6%, while South Korea’s KOSPI has dropped by 5%.

China’s CSI 300 index and Hong Kong’s Hang Seng index hit nearly one-month lows on Monday as investors braced for further trade uncertainty.

Morgan Stanley analysts noted that Asian hedge funds suffered losses of around 60 to 70 basis points last week, bringing their average monthly return down by 0.37%.

In response, these funds significantly reduced their net leverage, which fell by six percentage points to 61% compared to the previous week.

By region, hedge funds flipped to net sellers in South Korea, anticipating volatility from the country’s decision to lift a five-year short-selling ban.

They also unwound consumer stock positions in China and exited sizable holdings in Taiwan. The outflows were mainly driven by multi-strategy and macro funds, according to Morgan Stanley.

Broader hedge fund positioning

The retreat from Asian markets is part of a broader trend of hedge funds cutting exposure globally.

A separate report from Goldman Sachs said that hedge funds have significantly reduced their holdings in major emerging markets, maintaining a higher number of short positions than long ones in Latin American and Asian equities so far this year.

In Asia, March saw particularly heavy selling of stocks, according to Goldman Sachs data. Short positions, which bet on declining asset prices, outnumbered long bets, which anticipate gains.

Funds have also scaled back investments in stocks closely tied to economic cycles.

Companies such as auto-parts manufacturers, select jewellery brands, and home furnishing retailers—sectors that typically struggle during periods of weak consumer spending—have seen notable declines in hedge fund interest.

European auto stocks, once a favoured trade for hedge funds earlier this year, are now being offloaded.

Selling pressure has intensified since Trump announced a 25% tariff on imported cars and light trucks set to take effect on April 3, with additional duties on auto parts scheduled for May 3.

Speculators have increased short bets on the sector, driving the ratio of long to short positions to near historic lows, Goldman Sachs noted.

Meanwhile, hedge funds have been net buyers of stocks linked to metals prices in recent weeks, accumulating positions at multi-year highs, according to the bank’s analysis.

The post Hedge funds exit Asian markets ahead of US tariff announcement on April 2 appeared first on Invezz

Keep Reading
Politics

How auto sales are surging ahead of Trump’s tariffs on imported vehicles

The US auto industry saw a surge in sales last month as consumers rushed to purchase vehicles ahead of President Donald Trump’s new tariffs on imported cars and parts.

Several major automakers reported sharp increases in sales for March, as buyers sought to avoid the price hikes expected once the tariffs take effect.

“This past weekend was by far the best weekend I’ve seen in a very long time,” Randy Parker, the chief executive of Hyundai Motor North America, told reporters on Tuesday.

The company reported a 13% increase in March sales on Monday compared with a year earlier.

Ford Motor Company saw an even bigger jump, with a 19% rise in March sales at dealerships.

However, the company’s overall first-quarter sales dropped by 1% to about 500,000 vehicles due to weaker fleet sales.

General Motors did not disclose a separate figure for March, but its first-quarter sales rose 17% year-over-year, reaching 693,000 vehicles.

The rush to buy comes ahead of Trump’s planned 25% tariff on imported vehicles, set to take effect on Thursday.

The tariffs will extend to imported auto parts on May 3, posing a challenge even for cars assembled in the US, as many contain foreign components that make up more than half of their total value.

Analysts predict price hikes of over $10,000 for some models as automakers adjust to the new levies.

EVs and hybrids gain momentum

As overall sales climbed, electric vehicles (EVs) and hybrids experienced particularly strong growth, while traditional internal combustion engine (ICE) vehicles saw more modest increases or outright declines.

General Motors reported that its EV sales nearly doubled to 32,000 units in the first quarter, driven by the launch of the electric Equinox SUV, one of the most affordable EVs in the US market at a starting price of around $35,000.

Toyota saw hybrid and EV sales surge 44% in March to 113,000 units, making up nearly half of its total sales.

While Toyota remains dominant in the hybrid segment, its fully electric vehicle presence remains relatively small.

Ford said its hybrid sales rose 33% in the first quarter, while EV sales, including the Mustang Mach-E, climbed 12%.

Meanwhile, sales of ICE-powered cars dropped 5%.

Hyundai reported a 68% jump in hybrid sales, while EV sales edged up 3%.

BMW saw a 26% rise in EV sales, contributing to a 4% overall increase in its US sales for the first quarter.

Uncertainty looms over future pricing

Despite the strong March performance, automakers remain uncertain about how tariffs will impact their pricing strategies.

Hyundai and Kia, which operate factories in Georgia and Alabama, still import a significant number of vehicles from South Korea.

“We haven’t made any firm decisions yet,” Parker said.

However, he advised potential buyers not to wait, adding, “Don’t wait to buy tomorrow what you can buy today.”

The post How auto sales are surging ahead of Trump’s tariffs on imported vehicles appeared first on Invezz

Keep Reading
Business

Chainlink price prediction: giant megaphone pattern forms

The Chainlink price has pulled back in the past few months even after the network’s ecosystem continued to do well. LINK dropped to a low of $13 on Tuesday, down from the year-to-date high of $30. This article explains why the LINK price may stage a strong comeback in the long term. 

Chainlink price has formed a bullish pattern

The first main reason why the LINK price will soon stage a strong comeback is that it has formed a rare bullish chart pattern on the weekly chart. 

The chart below shows that the coin bottomed around $12. This was a notable level since it was along the ascending trendline that connects the lowest swings since June 12 of 2023. It has always bounced back whenever it dropped to this level. 

The Chainlink price has formed an ascending broadening wedge pattern, also known as a megaphone. It is known as a megaphone because of its resemblance. Historically, this pattern usually triggers a strong bullish breakout.

Therefore, it is likely to rebound as bulls target the upper side of this wedge at about $30, which is about 125% above the current level. This rebound will happen as long as the coin remains above the lower side of the megaphone pattern. 

A break below the lower side of the wedge will raise the probability of the LINK price falling to the psychological point at $10.

The caveat of this Chainlink price prediction is that it is based on the weekly chart. Historically, signals generated on this chart often take time to happen since each candlestick represents a week. For example, it has taken months for the coin to drop from the upper side of the megaphone to the lower side. 

Chainlink price chart | Source: TradingView

LINK has some solid fundamentals

Chainlink price will likely do well because of its solid fundamentals in the crypto industry, where it is the biggest oracle network. An oracle is a technology that helps to connect offchain data to the on-chain. It is widely used in the decentralized and centralized finance industries, providing price feeds and other services. 

Chainlink has also become a key player in the Real World Asset (RWA) tokenization industry. This crucial technology aims to tokenize real assets like real estate, art, and classic vehicles. 

Chainlink does that by using cross-chain interoperability protocol (CCIP). CCIP technology facilitates communication between chains like Base, Arbitrum, Ethereum, and Solana. It has been adopted by some of the biggest companies in the finance industry like Blackrock, JPMorgan and SWIFT.

SWIFT is notable in that it handles over $150 trillion in volume each year. It is aiming to use tokenization to boost speeds and cut costs of these transactions. 

Chainlink has also taken measures to boost its network. For example, the developers launched the Chainlink Payment Abstraction to the mainnet. 

This feature enables customers using the Chainlink technology to pay using other cryptocurrencies, which will then be converted into LINK. It will help to grow the network by reducing friction and reducing MEV.

There are also odds that the Chainlink will get a spot LINK ETF this year. A LINK fund will be useful in creating demand from United States investors. 

From a macro level, the coin will likely bounce back when the Federal Reserve slashes interest rates in response to Donald Trump’s trade war. This trade war has led many companies like PIMCO and Goldman Sachs to boost their recession odds. 

The post Chainlink price prediction: giant megaphone pattern forms appeared first on Invezz

Keep Reading